# Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging

> **NCT05135312** · PHASE4 · UNKNOWN · sponsor: **OptiSkin Medical** · enrollment: 10 (estimated)

## Conditions studied

- Psoriasis
- Psoriatic Arthritis
- Psoriatic Nail

## Interventions

- **DRUG:** Etanercept
- **DEVICE:** OCT

## Key facts

- **NCT ID:** NCT05135312
- **Lead sponsor:** OptiSkin Medical
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-09
- **Primary completion:** 2022-08-08
- **Final completion:** 2022-08-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05135312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05135312, "Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05135312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*